Uterine Cervical Neoplasms Clinical Trials

25 recruitingLast updated: June 17, 2026

There are 25 actively recruiting uterine cervical neoplasms clinical trials across 19 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3. Top locations include London, United Kingdom, Manchester, United Kingdom, Barcelona, Spain. Updated daily from ClinicalTrials.gov.


Uterine Cervical Neoplasms Trials at a Glance

25 actively recruiting trials for uterine cervical neoplasms are listed on ClinicalTrialsFinder across 6 cities in 19 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in London, Manchester, and Barcelona. Lead sponsors running uterine cervical neoplasms studies include Cancer Research UK, Centre Hospitalier Universitaire de Nīmes, and Bangladesh University of Engineering and Technology.

Browse uterine cervical neoplasms trials by phase

Treatments under study

About Uterine Cervical Neoplasms Clinical Trials

Looking for clinical trials for Uterine Cervical Neoplasms? There are currently 24 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Uterine Cervical Neoplasms trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Uterine Cervical Neoplasms clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 25 trials

Recruiting
Phase 2

A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer

Uterine Cervical Neoplasms, Recurrent; Uterine Cervical Neoplasms, Metastatic; Vulvar Neoplasms; Vaginal Neoplasms
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology30 enrolled1 locationNCT07424664
Recruiting
Phase 2

Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer

Uterine Cervical NeoplasmsLocally Advanced
Sun Yat-sen University103 enrolled1 locationNCT07646301
Recruiting

Post-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy

Uterine Cervical Neoplasms
Centre Paul Strauss80 enrolled2 locationsNCT07204535
Recruiting
Phase 1

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer1,006 enrolled159 locationsNCT04389632
Recruiting
Phase 1Phase 2

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckOvarian Neoplasms+8 more
Cancer Research UK167 enrolled4 locationsNCT06380816
Recruiting
Phase 2

A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

Ovarian NeoplasmsUterine Cervical NeoplasmsEndometrial Neoplasms+3 more
Yonsei University198 enrolled27 locationsNCT06023862
Recruiting
Not Applicable

Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women

Uterine Cervical Neoplasms
ISA Associates, Inc.288 enrolled2 locationsNCT07011836
Recruiting
Not Applicable

Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer

Uterine Cervical NeoplasmsCervical CancersCervical Intraepithelial Neoplasia+1 more
DL Analytics10,000 enrolled1 locationNCT06815939
Recruiting
Phase 1

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

Carcinoma, Non-Small Cell LungOvarian NeoplasmsUterine Cervical Neoplasms+4 more
Eli Lilly and Company495 enrolled23 locationsNCT06400472
Recruiting

A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer

Uterine Cervical NeoplasmsCervical Cancer by FIGO Stage 2018
Centre Hospitalier Universitaire de Nīmes120 enrolled1 locationNCT07305727
Recruiting

Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe

Uterine Cervical NeoplasmsHPV InfectionHIV I Infection
University of Bern250 enrolled1 locationNCT07202936
Recruiting
Phase 1Phase 2

HTL0039732 in Participants With Advanced Solid Tumours

SarcomaUrinary Bladder NeoplasmsUterine Cervical Neoplasms+11 more
Cancer Research UK150 enrolled5 locationsNCT05944237
Recruiting
Not Applicable

Neoadjuvant Therapy in Cervical Cancer

Uterine Cervical Neoplasms
Qilu Hospital of Shandong University48 enrolled1 locationNCT06558682
Recruiting
Not Applicable

Exploratory Study on NIRFI Technology Combined with ICG Guided Cervical Cancer Lymph Node Metastasis

Uterine Cervical Neoplasms
Obstetrics & Gynecology Hospital of Fudan University15 enrolled1 locationNCT06840418
Recruiting
Not Applicable

Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings

Uterine Cervical Neoplasms
National Healthcare Group Polyclinics650 enrolled1 locationNCT06528184
Recruiting

AI Model for Cervical Cancer Detection From Colposcopy Images

Uterine Cervical Neoplasms
Bangladesh University of Engineering and Technology500 enrolled1 locationNCT06644248
Recruiting
Phase 3

Comparison of Conventional and Hypofractionated IMRT in High-Risk Cervical Cancer Post-Radical Hysterectomy

Uterine Cervical Neoplasms
Samsung Medical Center248 enrolled1 locationNCT06509724
Recruiting
Phase 2

Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer

Uterine Cervical Neoplasms
Hospital Israelita Albert Einstein112 enrolled14 locationsNCT05492123
Recruiting
Not Applicable

PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer

Uterine Cervical NeoplasmsLocally Advanced Cervical Carcinoma
Leiden University Medical Center30 enrolled2 locationsNCT05406856
Recruiting
Not Applicable

Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy

LymphedemaUterine Cervical NeoplasmsEndometrial Neoplasms+1 more
Chongqing University Cancer Hospital400 enrolled1 locationNCT05793749